Zobrazeno 1 - 10
of 110
pro vyhledávání: '"Nooij, M.A."'
Autor:
Jansen-Landheer, M.L.E.A., Krijnen, P., Oostindiër, M.J., Kloosterman-Boele, W.M., Noordijk, E.M., Nooij, M.A., Steup, W.H., Taminiau, A.H.M., Vree, R., Hogendoorn, P.C.W., Tollenaar, R.A.E.M., Gelderblom, H.
Publikováno v:
In European Journal of Surgical Oncology 2009 35(12):1326-1332
Autor:
Rodenhuis, S. *, Bontenbal, M., van Hoesel, Q.G.C.M., Smit, W.M., Nooij, M.A., Voest, E.E., van der Wall, E., Hupperets, P., van Tinteren, H., Peterse, J.L., van de Vijver, M.J., de Vries, E.G.E.
Publikováno v:
In Annals of Oncology April 2006 17(4):588-596
Autor:
Nooij, M.A, de Haes, J.C.J.M, Beex, L.V.A.M, Wildiers, J, Klijn, J, Becquart, D, Jassem, J, Engelsman, E, Duchateau, L
Publikováno v:
In European Journal of Cancer March 2003 39(5):614-621
Autor:
Wagenaar, H.C., Colombo, N., Vergote, I., Hoctin-Boes, G., Zanetta, G., Pecorelli, S., Lacave, A.J., van Hoesel, Q., Cervantes, A., Bolis, G., Namer, M., Lhommé, C., Guastalla, J.P., Nooij, M.A., Poveda, A., Scotto di Palumbo, V., Vermorken, J.B.
Publikováno v:
In Gynecologic Oncology June 2001 81(3):348-354
Autor:
Gelderblom, H., Jinks, R.C., Sydes, M., Bramwell, V.H.C., Glabbeke, M. van, Grimer, R.J., Hogendoorn, P.C.W., McTiernan, A., Lewis, I.J., Nooij, M.A., Taminiau, A.H.M., Whelan, J., European Osteosarcoma Intergrp
Publikováno v:
European Journal of Cancer, 47(6), 895-902
Background Recurrence after osteosarcoma usually leads to death; thus prognostic factors for survival are of great importance. Methods Between 1983 and 2002, the European Osteosarcoma Intergroup accrued 1067 patients to 3 randomized controlled trials
Autor:
Bontenbal, M., Nortier, J.W., Beex, L.V.A.M., Bakker, P.J.M., Hupperets, P.S.G.J., Nooij, M.A., Veelen, H. van, Vreugdenhil, G.R., Richel, D.J., Blijham, G.H.
Publikováno v:
Nederlands Tijdschrift voor Geneeskunde, 144, 21, pp. 984-989
Nederlands Tijdschrift voor Geneeskunde, 144, 984-989
Nederlands Tijdschrift voor Geneeskunde, 144, 984-989
Item does not contain fulltext
Autor:
Spreafico, Marta1,2 (AUTHOR) m.fiocco@math.leidenuniv.nl, Hazewinkel, Audinga-Dea3 (AUTHOR) dea.hazewinkel@lshtm.ac.uk, van de Sande, Michiel A. J.4,5 (AUTHOR) m.a.j.van_de_sande@lumc.nl, Gelderblom, Hans6 (AUTHOR) a.j.gelderblom@lumc.nl, Fiocco, Marta1,2,7 (AUTHOR)
Publikováno v:
Cancers. Aug2024, Vol. 16 Issue 16, p2880. 17p.
Autor:
Spreafico, Marta1,2 (AUTHOR) m.fiocco@math.leidenuniv.nl, Hazewinkel, Audinga-Dea3 (AUTHOR) dea.hazewinkel@lshtm.ac.uk, Gelderblom, Hans4 (AUTHOR) a.j.gelderblom@lumc.nl, Fiocco, Marta1,2,5 (AUTHOR)
Publikováno v:
Current Oncology. Jul2024, Vol. 31 Issue 7, p3630-3642. 13p.
Autor:
Medeiros, Mariana1 (AUTHOR) marianamedeiros@usp.br, Guenka, Sophia2 (AUTHOR) sogpdibb@usp.br, Bastos, David2 (AUTHOR) dbastos60@usp.br, Oliveira, Karla Laissa3 (AUTHOR) karlalaissa@hotmail.com, Brassesco, María Sol2 (AUTHOR) solbrassesco@usp.br
Publikováno v:
Pharmaceuticals (14248247). Jun2024, Vol. 17 Issue 6, p734. 33p.
Autor:
Hamilton, A., Biganzoli, L., Coleman, R., Mauriac, L., Hennebert, P., Awada, A., Nooij, M.A., Beex, L.V.A.M., Piccart, M., Hoorebeeck, I. van, Bruning, P., Valeriola, D. de
Publikováno v:
Annals of Oncology, 13, 910-8
Annals of Oncology, 13, 6, pp. 910-8
Annals of Oncology, 13, 6, pp. 910-8
Item does not contain fulltext BACKGROUND: We performed a phase I study of polyethylene glycol (pegylated, Stealth) liposomal doxorubicin (Caelyx, Doxil) using a prolonged (6-week) dose interval to reduce the incidence of skin toxicity that was dose-
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::226d6fae25db44e0cf6565d525c47252
http://hdl.handle.net/2066/185317
http://hdl.handle.net/2066/185317